Advanz Claims A First With German Lanreotide Launch
Pushes Into Complex And Value-Added Medicines With Somatuline Rival
Executive Summary
Advanz has claimed a first with a European launch of a rival to Ipsen’s Somatuline, introducing its generic lanreotide in Germany under the name Mytolac.